{
    "clinical_study": {
        "@rank": "95859", 
        "arm_group": {
            "arm_group_label": "LDV/SOF", 
            "arm_group_type": "Experimental", 
            "description": "Treatment-experienced and treatment-naive participants will receive LDV/SOF for 12 weeks."
        }, 
        "brief_summary": {
            "textblock": "This study will evaluate the antiviral efficacy of ledipasvir (LDV)/sofosbuvir (SOF)\n      fixed-dose combination (FDC) in treatment-naive and treatment-experienced Korean and\n      Taiwanese participants with chronic genotype 1 Hepatitis C Virus (HCV) infection.\n      Participants will receive 12 weeks of treatment and continue assessments during a 24-week\n      follow-up period."
        }, 
        "brief_title": "Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Korean and Taiwanese Participants With Chronic Genotype 1 HCV Infection", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic HCV Infection", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Willing and able to provide written informed consent\n\n          -  HCV RNA \u2265 10^4 IU/mL at screening\n\n          -  HCV treatment-na\u00efve (HCV genotype 1), as defined as no prior exposure to any\n             interferon (IFN), ribavirin (RBV) or other approved or experimental HCV-specific\n             direct-acting antiviral agent; OR HCV treatment-experienced with medical records that\n             include sufficient detail of prior treatment with IFN to allow for categorization of\n             prior response as either IFN intolerant, non-responder, or experienced viral\n             breakthrough or relapse.\n\n          -  HCV infection documented by anti-HCV antibody test, genotyping test, or liver biopsy\n\n        Exclusion Criteria:\n\n          -  Pregnant or nursing female or male with pregnant female partner\n\n          -  Chronic liver disease of a non-HCV etiology\n\n          -  Current or prior history of any clinically-significant illness (other than HCV)\n\n          -  Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02021656", 
            "org_study_id": "GS-US-337-0131"
        }, 
        "intervention": {
            "arm_group_label": "LDV/SOF", 
            "description": "LDV 90 mg/SOF 400 mg FDC tablet administered orally once daily", 
            "intervention_name": "LDV/SOF", 
            "intervention_type": "Drug", 
            "other_name": [
                "GS-7977", 
                "PSI-7977", 
                "GS-5885"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 10, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Ansan-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "425-707"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucheon", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "420-767"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "405-760"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seongnam-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "467-707"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of", 
                        "zip": "602-715"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of", 
                        "zip": "602-739"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of", 
                        "zip": "614-735"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of", 
                        "zip": "700-721"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "138-736"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "152-703"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "120-752"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-720"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "735-710"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "137-701"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changhua City", 
                        "country": "Taiwan", 
                        "zip": "50006"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaohsiung City", 
                        "country": "Taiwan", 
                        "zip": "82445"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaohsiung City", 
                        "country": "Taiwan", 
                        "zip": "80708"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaohsiung City", 
                        "country": "Taiwan", 
                        "zip": "83301"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Keelung city", 
                        "country": "Taiwan", 
                        "zip": "20401"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taichung City", 
                        "country": "Taiwan", 
                        "zip": "40447"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tainan City", 
                        "country": "Taiwan", 
                        "zip": "70457"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tainan city", 
                        "country": "Taiwan", 
                        "zip": "73657"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei City", 
                        "country": "Taiwan", 
                        "zip": "10449"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei City", 
                        "country": "Taiwan", 
                        "zip": "10048"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei City", 
                        "country": "Taiwan", 
                        "zip": "11217"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taoyuan County", 
                        "country": "Taiwan", 
                        "zip": "33305"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Korea, Republic of", 
                "Taiwan"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Korean and Taiwanese Subjects With Chronic Genotype 1 HCV Infection", 
        "overall_official": {
            "affiliation": "Gilead Sciences", 
            "last_name": "Kathryn Kersey", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Taiwan : Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "SVR12 is defined as HCV RNA < the lower limit of quantitation (LLOQ; ie, < 25 IU/mL) 12 weeks following the last dose of study drug.", 
                "measure": "Proportion of participants with sustained virologic response 12 weeks after discontinuation of therapy (SVR12)", 
                "safety_issue": "No", 
                "time_frame": "Post-treatment Week 12"
            }, 
            {
                "measure": "Proportion of participants who permanently discontinue study drug due to an adverse event", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 12"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02021656"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "SVR4 and SVR24 is defined as HCV RNA < LLOQ at 4 and 24 weeks following the last dose of study drug, respectively.", 
                "measure": "Proportion of participants with sustained virologic response at 4 and 24 weeks after discontinuation of therapy (SVR4 and SVR24)", 
                "safety_issue": "No", 
                "time_frame": "Post-treatment Weeks 4 and 24"
            }, 
            {
                "description": "Viral breakthrough is defined as having achieved undetectable HCV RNA levels (HCV RNA < LLOQ) during treatment, but did not achieve a sustained virologic response (SVR).", 
                "measure": "Proportion of participants experiencing viral breakthrough", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 12"
            }, 
            {
                "description": "Viral relapse is defined as having achieved undetectable HCV RNA levels (HCV RNA < LLOQ) within 4 weeks of end of treatment, but did not achieve an SVR.", 
                "measure": "Proportion of participants experiencing viral relapse", 
                "safety_issue": "No", 
                "time_frame": "Week 12 to post-treatment Week 24"
            }, 
            {
                "measure": "HCV RNA change from baseline", 
                "safety_issue": "No", 
                "time_frame": "Baseline to post-treatment Week 24"
            }
        ], 
        "source": "Gilead Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gilead Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}